ETF Holdings Breakdown of RPRX

Stock NameRoyalty Pharma Plc
TickerRPRX(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINGB00BMVP7Y09
LEI549300FGFN7VOK8BZR03

News associated with RPRX

After Hours Most Active for Jun 24, 2025 : SNAP, NVDA, CMCSA, PLTR, INTC, SPR, AUR, RPRX, KVUE, MPW, GM, WMT
The NASDAQ 100 After Hours Indicator is down -.81 to 22,189.71. The total After hours volume is currently 173,627,396 shares traded.The following are the most active stocks for the after hours session: Snap Inc. (SNAP) is unchanged at $8.32, with 14,501,942 shares traded. SNAP's - 2025-06-24 20:24:56
Manning & Napier Advisors LLC Sells 44,505 Shares of Royalty Pharma PLC (NASDAQ:RPRX)
Manning & Napier Advisors LLC lessened its holdings in shares of Royalty Pharma PLC (NASDAQ:RPRX – Free Report) by 54.9% during the first quarter, HoldingsChannel.com reports. The firm owned 36,549 shares of the biopharmaceutical company’s stock after selling 44,505 shares during the quarter. Manning & Napier Advisors LLC’s holdings in Royalty Pharma were worth $1,138,000 […] - 2025-06-24 08:20:57
After Hours Most Active for Jun 11, 2025 : PLTR, NVDA, AMZN, AAPL, RPRX, MCHPP
The NASDAQ 100 After Hours Indicator is up 14.32 to 21,875.12. The total After hours volume is currently 131,070,110 shares traded.The following are the most active stocks for the after hours session: Palantir Technologies Inc. (PLTR) is +0.25 at $136.64, with 5,538,416 shares t - 2025-06-11 20:24:56
Rhumbline Advisers Has $14.01 Million Position in Royalty Pharma plc (NASDAQ:RPRX)
Rhumbline Advisers lowered its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 0.9% during the first quarter, HoldingsChannel reports. The firm owned 449,964 shares of the biopharmaceutical company’s stock after selling 4,184 shares during the quarter. Rhumbline Advisers’ holdings in Royalty Pharma were worth $14,007,000 as of its most recent SEC […] - 2025-06-09 08:24:51
Lazard Asset Management LLC Reduces Holdings in Royalty Pharma plc (NASDAQ:RPRX)
Lazard Asset Management LLC lowered its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.6% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 23,457 shares of the biopharmaceutical company’s stock after selling 1,130 shares during the quarter. Lazard Asset […] - 2025-05-22 08:46:49
Royalty Pharma plc (NASDAQ:RPRX) Receives Average Rating of “Buy” from Brokerages
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has received a consensus recommendation of “Buy” from the five research firms that are covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the company. […] - 2025-05-22 07:50:51
Captrust Financial Advisors Sells 14,499 Shares of Royalty Pharma plc (NASDAQ:RPRX)
Captrust Financial Advisors reduced its position in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 49.4% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 14,829 shares of the biopharmaceutical company’s stock after selling 14,499 shares during the quarter. Captrust Financial Advisors’ holdings in Royalty Pharma were worth $378,000 as of […] - 2025-05-20 07:52:44
Royalty Pharma (NASDAQ:RPRX) Raised to “Buy” at StockNews.com
Royalty Pharma (NASDAQ:RPRX – Get Free Report) was upgraded by stock analysts at StockNews.com from a “hold” rating to a “buy” rating in a note issued to investors on Monday. Separately, Citigroup reiterated a “buy” rating on shares of Royalty Pharma in a research report on Friday, March 28th. One equities research analyst has rated […] - 2025-05-14 05:14:45
Stifel Financial Corp Lowers Stake in Royalty Pharma plc (NASDAQ:RPRX)
Stifel Financial Corp reduced its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 11.4% in the fourth quarter, Holdings Channel reports. The firm owned 17,152 shares of the biopharmaceutical company’s stock after selling 2,200 shares during the period. Stifel Financial Corp’s holdings in Royalty Pharma were worth $438,000 at the end […] - 2025-05-13 07:50:58
Prudential Financial Inc. Has $488,000 Stake in Royalty Pharma plc (NASDAQ:RPRX)
Prudential Financial Inc. lowered its holdings in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 4.9% during the fourth quarter, Holdings Channel.com reports. The firm owned 18,360 shares of the biopharmaceutical company’s stock after selling 955 shares during the period. Prudential Financial Inc.’s holdings in Royalty Pharma were worth $488,000 at the end of the […] - 2025-04-10 08:01:02
American Century Companies Inc. Boosts Holdings in Royalty Pharma plc (NASDAQ:RPRX)
American Century Companies Inc. grew its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 5.8% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 67,160 shares of the biopharmaceutical company’s stock after buying an additional 3,671 shares […] - 2025-04-10 07:26:56
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by JPMorgan Chase & Co.
JPMorgan Chase & Co. lifted its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 8.2% in the 4th quarter, Holdings Channel reports. The firm owned 1,395,242 shares of the biopharmaceutical company’s stock after purchasing an additional 105,824 shares during the quarter. JPMorgan Chase & Co.’s holdings in Royalty Pharma were worth $35,593,000 at […] - 2025-04-08 07:44:55
Schroder Investment Management Group Sells 354,483 Shares of Royalty Pharma plc (NASDAQ:RPRX)
Schroder Investment Management Group lowered its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 64.4% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 196,359 shares of the biopharmaceutical company’s stock after selling 354,483 shares during the quarter. Schroder Investment Management […] - 2025-04-06 08:29:08
Analysts Set Royalty Pharma plc (NASDAQ:RPRX) PT at $41.60
Shares of Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) have earned a consensus rating of “Buy” from the six research firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating […] - 2025-03-31 05:14:52
Stock Traders Buy High Volume of Royalty Pharma Put Options (NASDAQ:RPRX)
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) saw some unusual options trading on Thursday. Stock traders purchased 4,237 put options on the stock. This is an increase of 344% compared to the typical volume of 954 put options. Institutional Trading of Royalty Pharma Institutional investors and hedge funds have recently modified their holdings of […] - 2025-03-28 07:07:01
Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Corient Private Wealth LLC
Corient Private Wealth LLC lifted its position in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 86.0% during the fourth quarter, HoldingsChannel.com reports. The fund owned 46,249 shares of the biopharmaceutical company’s stock after acquiring an additional 21,383 shares during the period. Corient Private Wealth LLC’s holdings in Royalty Pharma were worth $1,180,000 at the […] - 2025-03-27 08:10:50
Royalty Pharma plc (NASDAQ:RPRX) Stake Lowered by HighTower Advisors LLC
HighTower Advisors LLC decreased its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 5.0% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 173,411 shares of the biopharmaceutical company’s stock after selling 9,177 shares during the period. HighTower Advisors […] - 2025-03-20 07:45:04
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by M&T Bank Corp
M&T Bank Corp boosted its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 25.2% during the 4th quarter, HoldingsChannel reports. The fund owned 23,467 shares of the biopharmaceutical company’s stock after buying an additional 4,718 shares during the period. M&T Bank Corp’s holdings in Royalty Pharma were worth $599,000 as of its most […] - 2025-03-13 07:47:00
Royalty Pharma plc (NASDAQ:RPRX) Shares Acquired by Victory Capital Management Inc.
Victory Capital Management Inc. raised its holdings in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 15.2% in the 4th quarter, HoldingsChannel.com reports. The fund owned 978,211 shares of the biopharmaceutical company’s stock after buying an additional 129,176 shares during the quarter. Victory Capital Management Inc.’s holdings in Royalty Pharma were worth $24,954,000 […] - 2025-03-11 08:58:55
State of Michigan Retirement System Buys 2,700 Shares of Royalty Pharma plc (NASDAQ:RPRX)
State of Michigan Retirement System boosted its stake in shares of Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 16.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 19,400 shares of the biopharmaceutical company’s stock after purchasing an additional […] - 2025-03-10 08:44:52
Allworth Financial LP Raises Position in Royalty Pharma plc (NASDAQ:RPRX)
Allworth Financial LP lifted its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 417.6% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 1,087 shares of the biopharmaceutical company’s stock after acquiring an additional 877 shares during the quarter. Allworth Financial LP’s holdings in Royalty Pharma were worth $28,000 as of […] - 2025-02-27 08:28:51
Royalty Pharma (NASDAQ:RPRX) Reaches New 52-Week High on Strong Earnings
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) shares reached a new 52-week high during mid-day trading on Tuesday following a stronger than expected earnings report. The stock traded as high as $32.72 and last traded at $32.15, with a volume of 1138540 shares traded. The stock had previously closed at $31.72. The biopharmaceutical company […] - 2025-02-12 06:37:01
Royalty Pharma plc (NASDAQ:RPRX) Shares Sold by Mirae Asset Global Investments Co. Ltd.
Mirae Asset Global Investments Co. Ltd. decreased its position in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 1.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 75,068 shares of the biopharmaceutical company’s stock after selling 966 shares during […] - 2025-02-11 09:59:05
Royalty Pharma plc (NASDAQ:RPRX) Receives Consensus Rating of “Buy” from Brokerages
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has earned a consensus rating of “Buy” from the seven analysts that are currently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation, five have assigned a buy recommendation and one has given a strong buy recommendation to […] - 2025-02-11 09:04:54
Royalty Pharma plc (NASDAQ:RPRX) Shares Purchased by Blue Trust Inc.
Blue Trust Inc. boosted its position in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 31.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,579 shares of the biopharmaceutical company’s stock after acquiring an additional 376 shares during the quarter. Blue Trust Inc.’s holdings […] - 2025-02-10 18:12:59

RPRX institutional holdings

The following institutional investment holdings of RPRX have been identified

Date ETF ISIN/Name Num Shares Book value
2025-06-23 IE00B4L5Y983 (iShares Core MSCI World UCITS ETF USD (Acc)) 486,069USD 17,206,843
2025-06-23 IE00BD45YS76 (iShares Core MSCI World UCITS ETF GBP Hedged (Dist)) 486,069USD 17,206,843 1.5%
2025-06-23 IE00BKBF6H24 (iShares Core MSCI World UCITS ETF) 486,069USD 17,206,843
2025-06-23 IE000OHHIBC6 (iShares Core MSCI World UCITS ETF USD (Dist)) 486,069USD 17,206,843
2025-06-23 IE00BHZPJ890 (iShares MSCI USA ESG Enhanced UCITS ETF USD (Dist)) 788,148USD 27,900,439 1.5%
2025-06-23 IE00B6R52259 (iShares MSCI ACWI UCITS ETF) 78,873USD 2,792,104 1.5%
2025-06-23 IE00BFNM3G45 (iShares MSCI USA ESG Screened UCITS ETF USD (Acc)) 105,144USD 3,722,098
2025-06-23 IE00BFNM3H51 (iShares MSCI USA ESG Screened UCITS ETF USD (Dist)) 105,144USD 3,722,098
2025-06-23 IE000G2LIHG9 (iShares MSCI USA ESG Screened UCITS ETF EUR Hedged (Acc)) 105,144USD 3,722,098
2025-06-23 IE00B0M62Q58 (iShares MSCI World UCITS ETF USD (Dist)) 44,139 -0.2%USD 1,562,521 1.3%
2025-06-23 IE00BHZPJ569 (iShares MSCI World ESG Enhanced UCITS ETF USD Acc GBP) 157,833USD 5,587,288
2025-06-23 IE00BG11HV38 (iShares MSCI World ESG Enhanced UCITS ETF USD Inc GBP) 157,833USD 5,587,288
2025-06-23 IE00BP3QZB59 (iShares Edge MSCI World Value Factor UCITS ETF) 134,097USD 4,747,034
2025-06-23 IE00BFYTYS33 (iShares Edge MSCI World Value Factor UCITS USD Dist) 134,097USD 4,747,034 1.5%
2025-06-23 IE00BFNM3K80 (iShares MSCI World ESG Screened UCITS ETF USD (Dist)) 33,479USD 1,185,157
2025-06-23 IE00BFNM3J75 (iShares MSCI World ESG Screened UCITS ETF) 33,479USD 1,185,157
2025-06-23 IE00B441G979 (iShares MSCI World EUR Hedged UCITS ETF (Acc)) 20,931USD 642,606 1.4%
2025-06-23 IE00BD1F4M44 (iShares Edge MSCI USA Value Factor UCITS ETF USD (Acc) GBP) 159,654USD 5,651,752
2025-06-23 IE00BFF5RX68 (iShares Edge MSCI USA Value Factor UCITS ETF USD (Dist)) 159,654USD 5,651,752
2025-06-23 IE00B52SFT06 (iShares MSCI USA UCITS ETF USD (Acc)) 16,713USD 591,640
2025-06-23 IE00B14X4M10 (iShares MSCI North America UCITS ETF USD (Dist) USD) 7,489USD 265,111
2025-06-23 IE00BJ5JNZ06 (iShares MSCI World Health Care Sector ESG UCITS ETF) 7,861USD 278,279
2025-06-23 IE0009QS7W62 (iShares MSCI World Health Care Sector ESG UCITS ETF USD (Acc)) 7,861USD 278,279
2025-06-23 IE00BKM4H312 (iShares MSCI USA Dividend IQ UCITS) 51,409USD 1,819,879
2025-06-23 IE00BZ0PKT83 (iShares Edge MSCI World Multifactor UCITS ETF USD (Acc) GBP) 19,804USD 701,062
2025-06-23 IE00BYXPXK00 (iShares STOXX World Equity Multifactor UCITS ETF EUR Hedged (Acc)) 19,804USD 701,062 1.5%
2025-06-23 IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) 208,429USD 7,378,387
2025-06-23 IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) 208,429USD 7,378,387
2025-06-23 IE00BN92ZL31 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Dist)) 11,806USD 417,932
2025-06-23 IE00BMXC7W70 (iShares MSCI World Paris-Aligned Climate UCITS ETF USD (Acc)) 11,806USD 417,932
2025-06-23 IE000OKVTDF7 (iShares MSCI USA Value Factor ESG UCITS ETF USD (Acc)) 7,025USD 248,685
2025-06-23 IE00B42YS929 (iShares MSCI World GBP Hedged UCITS ETF (Acc)) 2,513USD 65,953
2025-06-23 IE00BP3QZD73 (iShares MSCI World Mid-Cap Equal Weight UCITS ETF USD (Acc)) 11,738USD 415,525
2025-06-23 IE00BD1F4K20 (iShares MSCI USA Mid-Cap Equal Weight UCITS ETF USD (Acc)) 30,458USD 1,078,213
2025-06-23 IE00BZ0PKS76 (iShares STOXX USA Equity Multifactor UCITS ETF USD (Acc)) 4,034USD 142,804
2025-06-23 IE00BG13YZ23 (iShares Edge MSCI USA Multifactor UCITS ETF USD (Dist)) 4,034USD 142,804 1.5%
2025-06-23 IE0002EKOXU6 (iShares Russell 1000 Value UCITS ETF) 2,904USD 102,802
2025-06-23 IE00019GPKX6 (iShares MSCI ACWI UCITS ETF SGD Hedged (Acc)) 78,873USD 2,792,104 1.5%
2024-11-08 IE000X08RX14 (iShares MSCI World ESG Enhanced UCITS ETF NZD Hedged (Acc)) 7,987USD 209,339 -1.2%
2025-06-23 IE00BYX2JD69 (iShares MSCI World SRI UCITS ETF) 206,540USD 7,311,516
2025-06-23 IE00BMZ17T93 (iShares MSCI World SRI UCITS ETF GBP Hedged (Dist) GBP) 206,540USD 7,311,516
2025-06-23 IE00BMZ17X30 (iShares MSCI World SRI UCITS ETF USD Hedged (Dist)) 206,540USD 7,311,516 1.5%
2025-06-23 IE00BYVJRR92 (iShares MSCI USA SRI UCITS ETF USD (Acc)) 120,699USD 4,272,745 1.5%
2025-06-23 IE00BZ173V67 (iShares MSCI USA SRI UCITS ETF EUR Hedged (Dist)) 120,699USD 4,272,745
2025-06-23 IE00BZ173T46 (iShares MSCI USA SRI UCITS ETF USD (Dist)) 120,699USD 4,272,745
2025-06-23 IE00BMWPV470 (iShares MSCI USA SRI UCITS ETF GBP Hedged (Dist)) 120,699USD 4,272,745 1.5%
2025-06-23 IE00BP3QZ825 (iShares Edge MSCI World Momentum Factor UCITS ETF) 43,178 0.4%USD 1,528,501 1.9%
2025-06-23 IE00BKVL7778 (iShares Edge MSCI World Minimum Volatility ESG UCITS ETF USD (Acc)) 15,667USD 554,612 1.5%
2025-06-23 IE00BD1F4N50 (iShares Edge MSCI USA Momentum Factor UCITS ETF USD (Acc) GBP) 15,460 -1.4%USD 547,284 0.1%
2025-06-23 IE00BFF5RZ82 (iShares Edge MSCI USA Momentum Factor UCITS ETF USD (Dist)) 15,460 -1.4%USD 547,284 0.1%
2025-06-23 IE00013A2XD6 (iShares MSCI ACWI SRI UCITS ETF USD(Dist)) 1,926USD 68,180
2025-06-23 IE0002PA3YE5 (iShares MSCI USA Momentum Factor ESG UCITS ETF USD (Acc)) 370USD 13,098
2025-06-23 IE00BMTX1Y45 (iShares S&P 500 Swap UCITS ETF USD (Acc)) 73,966USD 2,618,396
2025-06-23 IE000D3BWBR2 (iShares S&P 500 Swap UCITS ETF USD (Dist)) 73,966USD 2,618,396
Total =6,225,311 USD 220,181,256
Book value of shares is calculated on the adjusted close price of each day (row).

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.